Clinical Trials in Philadelphia

Showing 17781-17800 of 20,904 trials

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

NCT02091596

This will be a randomized, double-blind (evaluator-blind), vehicle-controlled study of 50 enrolled subjects. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone). Subjects must also provide informed consent and meet all other entry criteria to be enrolled and randomly assigned to receive PluroGel N or PluroGel vehicle.

Diabetic Foot UlcerInfection

PluroGen Therapeutics, Inc42 participantsStarted Oct 2013

Phoenix, Arizona, United States • Los Angeles, California, United States • Oakland, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

NCT02119754

This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.

Diabetic Foot UlcerInfection

PluroGen Therapeutics, Inc15 participantsStarted Oct 2013

Phoenix, Arizona, United States • Los Angeles, California, United States • Oakland, California, United States +12 more locations

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

Find Trials by Condition in Philadelphia

Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

The OMEGA Clinical Trial

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults